Research Articles

1) Kidd M, Siddique Z-L, Drozdov I, Gustafsson BI, Camp RL, Black JW, Boyce M, MODLIN IM. The CCK2 receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development. Regul Pept. 2010 Jun 8;162(1-3):52-60.
2) Svejda B, Kidd M, Giovinazzo F, Eltawil K, Gustafsson BI, Pfragner R, MODLIN IM. The 5-HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment. Cancer 2010; 116(2):2902-12.
3) Drozdov I, Kidd M, Gustafsson BI, Joseph R, Pfragner R, MODLIN IM. The Auto-regulatory Effect of Serotonin on the Proliferation and Associated Signaling Pathway of Lung and Small Intestine Neuroendocrine Cell Lines. Cancer 2009 Nov1;115(21):4934-45.
4) Kidd M, Hauso Ø, Drozdov I, Gustafsson BI, MODLIN IM. Delineation of the chsemomechanosensory regulation of gastrin secretion using pure rodent G cells. Gastroenterology 2009 Jul;137(1):231-41, 241.e1-10. Epub 2009 Jan 14.
5) Drozdov I, Kidd M, Nadler B, Camp R, Mane M, Gustafsson BI, Hauso O, MODLIN IM. Predicting Enterochromaffin Cell Neoplasia Using Gene Expression Profiling and Supervised Machine Learning. Cancer 2009; 115:1638-50.
6) MODLIN IM, Gustafsson BI, Drozdov I, Kidd M. Principal Component Analysis, Hierarchical Clustering, and Decision Tree Assessment of Plasma mRNA and Hormone Levels as an Early Detection Strategy for Small Intestinal Neuroendocrine (Carcinoid) Tumors. Annals Surgical Oncology 2009 Feb;16(2):487-98. Epub 2008 Dec 3.
7) Kidd M, Gustafsson BI, Drozdov I, MODLIN IM. Serotonin secretion from Crohn’s disease EC cells is increased and mediated by IL1b and LPS through TOLL receptor 4 (TLR4) activation of NFκb. Neurogastroenterology & Motility (2008) (Oct 25_ePub).
8) Siddique Z-L, Drozdov I, Floch J, Gustafsson BI, Stunes K, Pfragner R, Kidd M, MODLIN IM. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model. Neuroendocrinology 2009;89(4):458-70. Epub 2009 Mar 18.
9) Kidd M, MODLIN IM, Gustafsson BI, Drozdov I, Hauso O. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol 2008; 295:G260-72.
10)Kidd M, Drozdov I, Joseph R, Pfragner R, Culler M, MODLIN IM. Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines. 2008; 113:690-700.
11) Bornschein J, Kidd M, Eick GN, Pfragner R, MODLIN IM. Systematic Cytotoxic Analysis of Common Chemotherapeutic Agents On Lung and Small intestinal Carcinoid Cell lines. J Cancer Molecules 2008; 4: 47-54.
12) Kidd M, Schally AV, Pfragner R, Malfertheiner MV, MODLIN IM. Inhibition of Proliferation of Small Intestinal and Bronchopulmonary cell lines using analogues targeting receptors. Cancer 2008; 112:1404-14.
13) Sachs G, Shin JM, Munson K, Vagin O, Kidd M, MODLIN IM. Molecular Mechanisms in Therapy of Acid Related Diseases. Cellular and Molecular Life Sciences 2008; 65:264-81.
14) Kidd M, Nadler B, Mane SM, Eick GN, Champaneria MC, Pfragner R, MODLIN IM. GeneChip, geNorm and GI carcinoids: novel reference genes for real-time PCR. Physiological Genomics 2007; 30: 363-70.
15) Kidd M, MODLIN IM, Pfragner R, Eick GN, Champaneria MC, Chan AO, Camp RL, Mane SM. Small bowel Carcinoid (EC cell) Neoplasia exhibits TGF b1-Mediated regulatory abnormalities including Up-regulation of C-Myc and MTA1 Cancer 2007; 109: 2420-31.
16) Kidd M, MODLIN IM, Shapiro MD, Camp RL, Mane SM, Lye KD, Usinger W, Murren J. CTGF, intestinal stellate cells and carcinoid tumor fibrogenesis. World Journal of Gastroenterology 2007; 13:5208-16.
17) Kidd M, MODLIN IM, Black JW, Boyce M, Culler M. Examination of novel gastrin, somatostatin and dopamine receptor compounds on gastric enterochromaffin-like cell function. Regulatory Peptides 2007; 143:109-17.
18) Kidd M, MODLIN IM, Eick GN, Camp RL, Mane SM. The role of CCN2/CTGF in the proliferation of Mastomys ECL cells and gastric carcinoid development. Am J Physiol 2007 Jan;292(1):G191-200.
19) Kidd M, Eick GN, Mane SM, Nadler B, Champaneria MC, Pfragner R, MODLIN IM. Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin. J Mol Endocrinol. 2007; 38:181-92.
20) MODLIN IM, Kidd M, Pfragner R, Eick GN, Champaneria MC. The Functional Characterization of Normal and Neoplastic Human Enterochromaffin Cells. J Clinical Endocrinology and Metabolism 2006; 91:2340-8.
21) Kidd M, MODLIN IM, Eick GN, Champaneria MC. Isolation, Functional Characterization and Transcriptome of Mastomys Ileal Enterochromaffin Cells. Am J Physiol 2006 Nov;291(5):G778-91.
22) Kidd M, MODLIN IM, Shapiro MD, Camp RL, Mane SM, Lye KD, Usinger W, Murren J. CTGF, intestinal stellate cells and carcinoid tumor fibrogenesis. World J Gastro (2006) (in press).
23) Kidd M, MODLIN IM, Mane SM, Camp RL, Latic I, Zikusoka MN. The utility of molecular genetic signatures in the delineation of gastric neoplasia. Cancer 2006; 106:1480-88.
24) MODLIN IM, Kidd M, Latich I, Zikusoka MN, Eick G, Mane SM, Camp RL. Genetic differentiation of appendiceal carcinoid malignancy – a guide for the perplexed. Annals of Surgery 2006; 244:52-60.
25) Kidd M, MODLIN IM, Mane SM, Camp RL, Shapiro MD. Q RT-PCR detection of Chromogranin A: A new standard in the identification of neuroendocrine tumor disease. Annals of Surgery 2006; 204: 273-80.
26) Kidd M, MODLIN IM, Mane SM, Camp RL, Eick G, Latich I. The role of genetic markers, NAP1L1, MAGE-D2 and MTA1, in defining small intestinal carcinoid neoplasia. Annals of Surgical Oncology 2006; 13:253-62.
27) Zikusoka MN, Kidd M, Eick G, Latich I, MODLIN IM. Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 2005; 104:2292-309.
28) Shen Z, Xu S, Dewhirst FE, Paster BJ, Pena JA, Kidd M, MODLIN IM, Fox JG. A Novel Enterohepatic Helicobacter sp. H. natalensis Isolated from the Liver and Intestine of Rodents. Helicobacter 2005; 10: 59-70.
29) Kidd M, Eick G, Shapiro MD, Camp RL, Mane SM, MODLIN IM. Microsatellite instability and gene mutations in TGFbRII are absent in small bowel carcinoids. Cancer 2005, 103:229-36.
30) Kidd M, Hinoue T, Eick G, Lye KD, Wei Y, Mane SM, MODLIN IM. Global gene expression analysis of enterochromaffin-like cells in the Mastomys gastric mucosa identifies alterations in the activator protein-1 pathway. Physiol Genomics 2004; 20:131-142.
31) MODLIN IM, Kidd M, Lye KD, Wright NA. Gastric stem cells: an update. Keio J Med. 2003 Jun;52(2):134-7.
32) Stalberg P, Granberg D, Carling T, Wilander E, Eriksson B, Gobl A, Akerstrom G, Rastad J, MODLIN IM, Oberg K, Skogseid B. In situ RNA-RNA hybridisation of phospholipase C beta 3 shows lack of expression in neuroendocrine tumours. Anticancer Res. 2003; 23(3B):2227-32.
33) Saikawa Y, Kubota T, Otani Y, Kitajima M, MODLIN IM. Alteration of DNA methylation status induced by epidermal growth factor in gastric cancer cell line, MKN-74. Anticancer Res. 2003 Jan-Feb;23(1A):143-8.
34) Modlin IM, Kidd M. Case study: Ranitidine/Loxtidine in “Predictive value of rodent forestomach and gastric neuroendocrine tumors in evaluating carcinogenic risk to humans”. IARC Technical Publication No. 39 (2003):167-176.
35) Modlin IM, Kidd M. Praomys (Mastomys) natalensis as a model for gastric carcinoids in “Predictive value of rodent forestomach and gastric neuroendocrine tumors in evaluating carcinogenic risk to humans” IARC Technical Publication No. 39 (2003):109-119, 2003.
36) Gumbs AA, Bassi C, Moore PS, Falconi M, Frigerio I, Baron A, Piemonti L, MODLIN IM, Scarpa A. Overexpression of the Sm-Like Proto-Oncogene in Primary and Metastatic Pancreatic Endocrine Tumors. JOP. J Pancreas (Online) 2002; 3:109-115.
37) Young GO, Brown S, Stemmet N, Lastovica AJ, Louw JA, Marks IN, MODLIN IM, Kidd M. The pepsinogen releasing effect of Helicobacter pylori lipopolysaccharide. Helicobacter 2002 7:30-38.
38) Lauffer JM, Tang LH, Zhang T, Hinoue T, Rahbar S, Odo M, MODLIN IM, Kidd M. PACAP mediates the neural proliferative pathway of Mastomys Enterochromaffin-like cell transformation. Regulatory Peptides 2001; 102:157-164.
39) Saikawa Y, Kubota T, Otani Y, Kitajima M, MODLIN IM. Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells. Jpn J Cancer Res 2001; 92:1102-1109.
40) Peek RM, Wirth HP, Moss SF, Yang M, Abdalla AM, Tham KT, Zhang T, Tang LH, MODLIN IM, Blaser MJ. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterol 2000; 118:48-59.
41) Kidd M, Tang LH, MODLIN IM, Zhang T, Chin K, Holt PR, Moss S. Gastrin-Mediated Alterations in Gastric Epithelial Apoptosis and Proliferation in a Mastomys Rodent Model of Gastric Neoplasia. Digestion 2000:62:143-151.
42) Kidd M, Tang LH, Schmid S, Lauffer J, Louw JA, MODLIN IM. Helicobacter pylori Lipopolysaccharide Alters ECL Cell DNA Synthesis via a CD 14 Receptor and Polyamine Pathway in Mastomys. Digestion 2000:62:217-224.
43) Miu K, Sun L, Tang LH, MODLIN IM. Influence of Helicobacter pylori lipopolysaccharide on the function of enterochromaffin-like cells in vitro. Zhonghua Nei Ke Za Zhi 1999; 38:670-672.
44) Kolby L, Wangberg B, Ahlman H, MODLIN IM, Theodorsson E, Nilsson O. Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation. Regul Pept 1999; 85:115-123.
45) Lauffer JM, MODLIN IM, Tang LH. Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract. Regul Pept 1999; 84:1-12.
46) MODLIN IM, Tang LH. Cell and tumor biology of the gastric enterochromaffin-like cell. Ital J Gastroenterol Hepatol 1999; 31 Suppl 2:S117-30.
47) Schmid SW, MODLIN IM, Tang LH, Stoch A, Rhee S, Nathanson MH, Scheele GA, Gorelick FS. Telenzipine-sensitive muscarinic receptors on rat pancreatic acinar cells. Am J Physiol 1998; 274:G734-G741
48) MODLIN IM, Poulsom R. Trefoil peptides: mitogens, motogens or mirages? Clin Gastroenterol 1997; 25 Suppl 1:S94-100
49) John KD, Ballantyne GH, MODLIN IM. Octreotide acetate inhibits motility in the rabbit distal colon. Eur Sur Res 1997; 29:311-8
50) Kidd M, Miu K, Tang LH, Perez-Perez GI, Blaser MJ, Sandor A, MODLIN IM. Helicobacter pylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat enterochromaffin-like cells. Gastroenterology 1997; 113:1110-7
51) Tang LH, Luque EA, Efstathiou JA, Bortecen KH, Kidd M, Tarasova NI, MODLIN IM. Gastrin receptor expression and function during rapid transformation of the enterochromaffin-like cells in an African rodent. Regul Pept. 1997; 72:9-18
52) Tsunoda Y, MODLIN IM. Signal Transduction machinery of the Parietal Cell Secretory System. Biomedical Research 1997, 17: 403-428
53) Kolby L, Wangberg B, Ahlman H, MODLIN IM, Granerus G, Theodorsson E, Nilsson O. Histidine decarboxylase expression and histamine metabolism in gastric oxyntic mucosa during hypergastrinemia and carcinoid formation. Endocrinology 1996; 137: 4435-42
54) Wangberg B, Nilsson O, Theodorsson E, MOLDIN IM, Dahlstrom A, Ahlman H. The effect of vagotomy on enterochromaffin-like cells in the mastomys natalensis. J. Autonomic Nervous System 1996; 59:133-9
55) MODLIN IM, Zhu ZH, Tang LH, Kidd M, Lawton GP, Miu K, Powers RE, Goldenring JR, Pasikhov D, Soroka CJ. Evidence for a Regulatory Role for Histamine in Gastric Enterochromaffin-Like Cell Proliferation Induced by Hypergastrinemia. Digestion 1996, 57: 310-321
56) Borin JF, Tang LH, Kidd M, Kiu K, Bortecen KH, Sandor A, MODLIN IM. Somatostatin receptor regulation of gastric enterochromaffin-like cell transformation to gastric carcinoid. Surgery 1996, 120: 1026-32
57) Tang LH, MODLIN IM, Lawton GP, Kidd M, Chinery R. The Role of TGFa in the Enterochromaffin-like (ECL) cell Tumour Autonomy in an African Rodent Mastomys. Gastroenterol 1996, 111: 1212-1223
58) MODLIN IM, Tang LH. The Enterochromaffin-like cell: An Enigmatic Cellular Lesion (ECL). Gastroenterol 1996, 111: 783-810
59) Kidd M, Tang LH, Miu K, Lawton GP, Sandor A, MODLIN IM. Autoregulation of Enterochromaffin-like cell Histamine secretion via the Histamine 3 receptor subtype. Yale J Biol Med 1996, 69: 9-19.
60) Tang LH, MODLIN IM. Somatostatin Receptor Regulation of Gastric Carcinoid Tumors. Digestion 1996, 57 (Suppl 1): 11-14.
61) Goldenring JR, Ray GS, Soroka CJ, Smith J, MODLIN IM, Meise K, Coffey RJ. Over-Expression of Transforming Growth Factor- a Alters the Differentiation of Gastric Cell Lineages. Dig Dis Sci 1996, 41 (4): 773-784.
62) Longley BJ, Tyrrell L, Lu SZ, Ma Y-S, Langley K, Ding T-G, Duffy T, Jacobs P and MODLIN IM. Somatic c-KIT Activating Mutation in Uticaria Pigmentosa and Aggressive Mastocytosis; Establishement of Clonality in a Human Mast Cell Neoplasm. Nature Genetics 1996; 12 (3):312-314.
63) MODLIN IM, Lawton GP, Miu K, Kidd M, Luque EA, Sandor A, Tang LH. Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours. Ann R Coll Surg Engl 1996; 78: 133-138.
64) Sandor A, Kidd M, Lawton GP, Miu K, Tang LH, MODLIN IM. Neurohormonal Modulation of Rat Enterochromaffin-like Cell Histamine Secretion. Gastroenterology, 1996; 110:1084-1092.
65) Tang LH, Goldenring JR, Caufield T, MODLIN IM. A Novel Serine Kinase Activity Associated with Exocrine Secretory Granule Membranes. Am J Physiol 1995; 269: G481-489.
66) Geibel J, Abraham R, MODLIN IM, Sachs G. Gastrin Stimulation of Changes in Intracellular Ca2+ in Parietal Cells Depends on Levels of cAMP. Gastroenterology, 1995; 109:1060-1067.
67) Powers RE, Lawton GP, MODLIN IM. Genotoxicity, Carcinogenicity and Acid-Suppressing Medications. Pharmac. Ther. Vol. 65, pp. 303-317, 1995.
68) Delle Fave G, Helander H, Holt S, MODLIN IM, Powers R, Solcia E, Soll A, Tielemans, Wright NA. Acid Suppression and Gastric Mucosal Cell Biology. Dig Dis Sci 1995; Vol. 40 (2):121S-131S.
69) Wängberg B, Nilsson O, Theodorsson E, MODLIN IM, Dalhström A, Ahlman H. Are Enterochromaffin Like Cell Tumours Reversible? An Experimental Study on Gastric Carcinoids Induced in Mastomys by Histamine 2-Receptor Blockade. J Regul Pept 1995; 56, 19-33.
70) Quin JA, Sgambati SA, Goldenring JR, Basson MD, Fielding LP, MODLIN IM, Ballantyne GH. PYY Inhibition of VIP-Stimulated Ion Transport in the Rabbit Distal Ileum. J Surg Res 1995; 58, 111-115.
71) Lawton GP, Tang LH, Miu K, Gilligan CJ, Absood A, MODLIN IM. Adrenergic and cromolyn sodium modulation of ECL cell histamine secretion. J Surg       Res 1995; 58, 96-104.
72) Delle Fave G, Helander H, Holt S, MODLIN IM, Powers R, Solcia E, Soll A, Tielemans, Wright NA. Acid Suppression and Gastric Mucosal Cell Biology. Dig Dis Sci 1994 39 (9):1843-1852.
73) MODLIN IM, Lawton GP, Tang LH, Geibel J, Abraham, R, Darr U. The Mastomys Gastric Carcinoid: Aspects of ECL Cell Function. Digestion 1994; 55 (suppl 3):31-37.
74) MODLIN IM, Geibel J, Tang LH, Goldenring J. Characterization of Parietal Cell Confocal Microscopy. In: Molecular and Cellular Mechanisms of H+ Transport. Ed. B Hirst. Nato ASI Series H: Cell Biology Vol. 89: 329-340. Springer Verlag 1994.
75) Boron WF, Waisbren SJ, MODLIN IM, Geibel JP. Unique Permeability Barrier of the Apical Surface of Parietal and Chief Cells in Isolated Perfused Gastric Glands. J Exp Biol 1994; 196 247-360.
76) Goldenring JR, Soroka CJ, Shen KR, Tang LH, Rodriguez W, Vaughn HD, Stoch SA, MODLIN IM. Enrichment of rab11, a small GTP-binding protein, in gastric parietal cells. Am J Physiol 267 (Gastrointest. Liver Physiol. 30):G187-G194; 1994.
77) Basson MD, Beidler DR, Turowski G, Zarif A, MODLIN IM, Jena BP, Madri JA. Effect of Tyrosine Kinase Inhibition on Basal and Epidermal Growth Factor-Stimulated Human Caco-2 Enterocyte Sheet Migration and Proliferation. J Cell Physiol 160:491-501; 1994.
78) MODLIN, IM, Kumar RR, Soroka CJ, Ahlman H, Nilsson O. Goldenring JR. Histamine as an Intermediate Growth Factor in Genesis of Gastric ECLomas Associated with Hypergastrinemia in Mastomys. Dig Dis Sci,1994; 39: (7):1446-1453.
79) Waisbren SJ, Geibel J, Boron WF, MODLIN IM. Luminal perfusion of isolated gastric glands. Am J Physiol 266 (Cell Physiol.35): C1013-C1027, 1994.
80) Waisbren S, Geibel J, MODLIN IM, Boron W. Unusual Permeability Properties of Gastric Gland Cells. Nature 1994; 368(6469):332-335.
81) Frankel WL, Zhang W, Singh A, Klurfeld DM, Don S, Sakata T, MODLIN IM, Rombeau JL. Mediation of the Trophic Effects of Short-Chain Fatty Acids on the Rat Jejunum and Colon. Gastro 1994;106:375-380.
82) Ballantyne GH, Goldenring JR, Fleming FX, Rush S, Flint JS, Fielding LP, Binder HJ and MODLIN IM. Inhibition of vasoactive intestinal polypeptide-stimulated ion transport by a novel Y-receptor phenotype in the rabbit distal colon. Am J Physiol, 1993; 264:G848-854.
83) Tsunoda Y, MODLIN IM, Tyrosine kinase activities in the modulation of stimulated parietal cell secretion. Am J Physiol, 1993; 264:G351-G356.
84) Chough SP, Goldenring JR, Hurst RD, Ballantyne GH, MODLIN IM. Calcium Modulation of the Effects of Serotonin, Carbachol and Histamine on Rabbit Ileal Ion Transport. Yale J Biol Med; (66) 1993 pp. 1-16.
85) Basson MD, MODLIN IM, Turowski G, Madri JA. Enterocyte-matrix interactions in the healing of mucosal injury. Eur J Gastroenterol & Hepatology 1993, 5 (suppl 3):S21-S28.
86) MODLIN IM, Basson MD, Soroka CJ, Wright NA, Poulsom R, Chinnery R, Hanby A, Patel K, Rogers L, Alison M. Ulcer-induced alterations in cell phenotype and matrix and growth factor expression. European Jo of Gastroenterology & Hepatology 1993, 5 (suppl 3):S59-S67.
87) Tang LH, Miller MD, Goldenring JR, MODLIN IM, Hersey SJ. Partial agonism by gastrin for a cholecystokinin receptor mediating pepsinogen secretion. Am J Physiol. 265 (Gastrointest. Liver Physio. 28): G865-G872, 1993.
88) MODLIN IM, Tang LH, Lawton GP, Darr UM, Zhu Z, Soroka CJ. Enterochromaffin-like Cell Pathobiology of Mastomys. Conference on Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Ann NY Acad Sci, 1994; 733:365-381.
89) Goldenring JR, Shen RK, Vaughan JD, MODLIN IM. Identification of a Small GTP-binding Protein, Rab25, Expressed in the Gastrointestinal Mucosa, Kidney, and Lung. J Biological Chem l993; 268:18419-18422.
90) Adrian TE, Ballantyne GH, Longo We, Graham S, Basson MD, Tierney RP, MODLIN IM. Deoxycholate is a major releaser of peptide YY and enteroglucagon from the human colon. Gut 1993;34:1219-1224.
91) Ballantyne GH, Goldenring JR, Savoca PE, Kranz HK, Adrian TE, Bilchik AJ, MODLIN IM. Cyclic AMP-medicated release of peptide YY (PYY) from the isolated perfused rabbit distal colon.  Regulatory Peptides; 47 (1993) : 117-122.
92) MODLIN IM, Tang LH. A new look at an old hormone - gastrin. Elsevier Science Publishing. TEM 1993; 4:2.
93) Nilsson B, Wängberg L, Johansson E, Theodorsson E, Dahlstrom A, MODLIN IM, Ahlman H. Development of gastric carcinoids in mastomys during histamine2-receptor blockade. Agents Actions 38, Special Conference Issue 1993.
94) Nilsson O, Wangberg B, Johansson L, Theodorsson E, Dahlstrom A, MODLIN IM, Ahlman H. Rapid induction of enterochromaffinlike cell tumors by Histamine2 receptor blockade. Am J Pathol 1993; 142:1173-1185.
95) Leach SD, Bilchik AJ, Karapetian O, Gorelick FS, MODLIN IM. Influence of Chloroquine on diet-induced pancreatitis. Pancreas 1993; 8(1):64-69.
96) Characterization of membrane and cytoskeletal compartments in cultured parietal cells: Immunofluorescence and confocal microscopic examination. Eur J Cell Biol 1993; Feb.
97) Young GO, Stemmet N, Lastovica A, van der Merwe EL, Louw JA, MODLIN IM. Helicobacter pylori lipopolysaccharide stimulates gastric mucosal pepsinogen secretion. Aliment. Pharmacol. Ther. (1992) 6:169-177.
98) Tsunoda Y, Funasaka M, MODLIN IM, Hidaka H, Fox L, Goldenring J. An inhibitor of Ca2+/calmodulin-dependent protein kinase II, KN-62, inhibits cholingergic-stimulated parietal cell secretion. Am J Physiol 1992; 262(25):G118-G122.
99) Goldenring JR, Asher VA, Barreuther MF, Lewis JJ, Lohmann SM, Walter U, MODLIN IM. Dephosphorylation of cAMP-dependant protein kinase regulatory subunit in stimulated parietal cells. Am J Physiol 1992; 25(4):G763-G773.
100) Armstrong DN, Ballantyne GH, MODLIN IM. Erythromycin stimulates ileal motility by activation of dihydropyridine-sensitive calcium channels. J Surg Research 1992; 52:140-146.
101) Goldenring JR, Tsunoda Y, Stoch SA, Coffey RJ, MODLIN IM. Transforming growth factor-alpha (TGFa) inhibition of parietal cell secretion: structural requirements for activity. Reg Pep 1992; 43(1-2):37-47.
102) Funasaka M, Fox LM, Tang LH, MODLIN IM, Goldenring J. the major calmodulin-binding protein in rabbit parietal cells is CA2+/Calmodulin-dependent protein kinase II. Biochem Internat 1992; 27(6):1101-1109.
103) Frankel W, Zhang W, Singh A, Klurfeld D, Sakata T, MODLIN IM, Rombeau J. Stimulation of the autonomic nervous system (ans) mediates short-chain fatty acid (SCFA) - induced jejunal trophism. Surg Forum 1992; 43:24-25.
104) Tang LH, Stoch SA, MODLIN IM, Goldenring JR. Identification of rab2 as a         tubulovesicle-membrane associated protein in rabbit parietal cells. Biochem J 1992;   285:715-719.
105) Basson MD, MODLIN IM, Madri JA. Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest 1992; 90(1):15-23.
106) MODLIN IM, Kumar R, Nangia A, Soroka CJ, Pasikhov D, Goldenring JR. Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas. Surgery 1992; 112(6):1048-1058.
107) Dempsey PJ, Goldenring JR, Soroka CJ, MODLIN IM, McClure RW, Lind CD, Ahlquist DA, Pittelkow MR, Lee DC, Sandgren EP, Page DL, Coffey RJ. Possible role of transforming growth factor a in the pathogenesis of Ménétrier's Disease: Supportive Evidence from Humans and Transgenic Mice. Gastroenterology 1992;103(6):1950-1963.
108) Reubi JC, Waser B, Horisberger U, Halter F, Soroka CJ, Kumar RR, Goldenring JR, MODLIN IM. Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from Mastomys gastric tumors. Endocrinology 1992; 131(1):166-172.
109) Grady T, Saluja AK, Steer ML, Lerch MM, MODLIN IM, Powers RE. In vivo and in vitro effects of the AZT analogue dideoxyinosine (ddI) on the exocrine pancreas of the rat. J Pharmacol Exp Ther 1992; 262(1):445-449.
110) MODLIN, IM, Nangia AK. The Pathobiology of the Human Enterochromaffin-Like Cell. Yale J Biol and Med 1992; 65(6):775-792.
111) Goldenring JR, Tang LH, MODLIN IM. Small GTP-Binding Proteins in Parietal Cells: Candidate Modulators of Parietal Cell Membrane Dynamics. Yale J Biol and Med 1992; 65(6):597-605.
112) Gorelick FS, MODLIN IM, Leach SD, Carangelo R, Katz M. Intracellular Proteolysis of Pancreatic Zymogens. Yale J Biol and Med 1992; 65(5):407-420.
113) Vukasin AP, Ballantyne GH, MODLIN IM, Nilsson O, Bilchik AJ, Pernikoff BJ, Blair RM, Adrian TE. Plasma and tissue alterations of peptide YY and enteroglucagon in rats after colectomy. Yale J Biol and Med 1992; 65(1):1-15.
114) Basson MD, MODLIN IM, Flynn SD, Jena BP, Madri JA. Independent modulation of enterocyte migration and proliferation by growth factors, matrix proteins and pharmacologic agents in an in vitro model of mucosal healing. Surgery 1992; 112(2):299-308.
115) Basson MD, Goldenring JR, Tang LH, Lewis JJ, Padfield P, Jamieson J, MODLIN IM. Redistribution of 23 kDa tubulovesicle-associated GTP-binding proteins during parietal cell stimulation. Biochem J 1991; 279:43-48.
116) Leach SE, MODLIN IM, Scheele GA, Gorelick F. Intracellular activation of digestive zymogens in rat pancreatic acini: Stimulation by high doses of CCK. J Clin Invest 1991; 87(1):362-366.
117) Longo WE, Ballantyne GH, Savoca PE, Adrian TE, Bilchik AJ, MODLIN IM. Short Chain fatty acid release of peptide YY in the isolated rabbit colon. Scand J Gastro 1991; 26:442-448.
118) Armstrong DA, Ballantyne GH, Adrian TE, Bilchik AJ, McMillen MA, MODLIN IM. Adaptive increase in Peptide YY and enteroglucagon after proctocolectomy and pelvic ileal reservoic construction. Dis Col and Rectum 1991; 34(2):119-125.
119) MODLIN IM, Esterline W, Kim H, Goldenring JR. Enterochromaffin-like cells and gastric argyophil carcinoidosis. Acta Oncologica 1991; 30:493-498.
120) Nilsson O, Bilchik AJ, Goldenring JR, Ballantyne GH, Adrian TE, MODLIN IM. Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon. Endrocrinology 1991;             129(1):139-148.
121) Armstrong DN, Ballantyne GH, MODLIN IM. Peptide YY (PYY) and neuropeptide Y (NPY) reverse VIP inhibition of motility in isolated perfused rabbit ileum. Surgical Forum 1991; 42.
122) Neville R, Fielding LP, Cambria RP, MODLIN IM. Vascular responsiveness in obstructed gut. Dis Colon & Rectum Mar 1991; 34:229-235.
123) Savoca PE, Ballantyne GH, Bilchik AJ, MODLIN IM. Evidence for cholingergic regulation of deoxycholate stimulated PYY release in man. Diseases of the Colon & Rectum 1990; 33:31.
124) Flint SF, Ballantyne GH, Goldenring JR, Fielding LP, MODLIN IM. Neuropeptide Y inhibition of vasoactive intestinal polypeptide-stimulated ion transport in the rabbit distal colon. Arch of Surgery 1990; 33:34-35.
125) Flint SF, Ballantyne GH, Goldenring JR, Fielding LP, MODLIN IM. Peptide YY (PYY) inhibits VIP stimulated ion transport in the distal colon by increasing phosphodiesterase activity. Surg Forum 1990; 41:191-193.
126) MODLIN IM, Basson MD, Adrian TE, Sussman J. Pepsinogen release and acid secretion from human and guinea pig gastric mucosa compromised by hypoxia, endotoxin or critical illness. Scand J Gastro 1990; 25(9):861-875.
127) Ferrara AF, McMillen MA, Schaefer HC, Goldenring JR, Zucker KA, MODLIN IM. Effect of cholecystokinin receptor blockade on human lymphocyte to proliferation. J Surg Res 1990; 48:354-357.
128) Basson MD, Adrian TE, MODLIN IM. Effects of cholecystokinin and cholingergic receptor blockade on guinea pig pepsinogen secretion. Scand J Gastro 1990; 25:825-833.
129) MODLIN IM, Bilchik AJ, Nilsson O, Goldenring JR. Enterochromaffin-like cell tumor induction in mastomys by insurmountable H2-receptor blockade. Research & Clin Forums 1990; 12:59-73.
130) Lewis J, Goldenring J, Asher V, MODLIN IM. The effects of epidermal growth factor (EGF) on signal transduction in rabbit parietal cells. Am J Physio 1990; 258(3 part 1):G476-G483.
131) Lewis J, Goldenring J, MODLIN IM, Coffey R. Inhibition of parietal cell H+ secretion by transforming growth factor alpha: A possible autocrine regulatory mechanism. Surgery 1990; 108(2):220-227.
132) McMillen M, Ferrara A, Schaeffer H, Goldenring J, Zucker K, MODLIN IM. Cholecystokinin Mediates a Calcium Signal in Human Peripheral Blood Mononuclear Cells and Is a Co-mitogen: In Neuropeptides and Immunopeptides: Messengers in a Neuroimmune Axis: In Annals of the New York Academy of Sciences. M.Sue O'Dorisio and Alberto Panerai (eds), New York Academy of Sciences, New York 1990; 594:399-402.
133) Nilsson O, Bilchik AJ, Adrian TE, MODLIN IM. Intra-Ocular Transplantation of Carcinoid Tumours from Mastomys and Humans. J Path 1990; 160:347-354.
134) Bilchik AJ, Zucker KA, Adrian TE, Sussman J, MODLIN IM. Effects of a specific cholecystokinin receptor antagonist in a traumatic model of pancreatitis. Surg Res Comm 1990; 8(1):47 - 57.
135) Bilchik AJ, Nilsson O, MODLIN IM, Zucker KA, Adrian TE. Significance of gastric endocrine tumor and age-related gut peptide alterations in Mastomys. Reg Pep 1990; 27 (2):195 - 207.
136) Bilchik AJ, Zucker KA, Adrian TE, MODLIN IM. Amelioration of cholinergic-induced pancreatitis with a selective cholecystokinin receptor antagonist. Arch Surg Dec 1990; 125:1546-1549.
137) Savoca PE, Ballantyne GH, Bilchik AJ, Adrian TE, MODLIN IM. cAMP mediated release of PYY from the isolated perfused colon: evidence for negative feedback modulation of colonic secretion. Surgical Forum 1989; 40:177-180.
138) Ballantyne GH, Longo WE, Savoca PE, Adrian TE, Vukasin AP, Bilchik AJ, Sussman J, MODLIN IM. Deoxycholate-stimulated release of peptide YY from the isolated perfused rabbit left colon. Am J Physiol 1989; 257(5 pt 1): G715-G724.
139) Fleming FX, Ballantyne GH, Goldenring JP, Fielding LP, MODLIN IM. Paracrine modulation of vasoactive intestinal peptide (VIP) stimulated ion transport by peptide YY in the rabbit distal colon. Surgical Forum 1989; 40:184-186.
140) Bean AJ, Adrian TE, MODLIN IM, Roth RH. Dopamine and neurotensin storage in colocalized and non-colocalized neuronal populations. J Pharm & Exp Ther 1989; 249(3):681-687.
141) Adrian TE, Goldenring JR, Oddsdottir M, Zdon MJ, Zucker KA, Lewis JJ, MODLIN IM. A micro-method for the assay of cellular secretory physiology: Application to rabbit parietal cells. Anal Biochem 1989; 182(2):346-352.
142) Zdon MJ, Lewis JJ, Adrian TE, MODLIN IM. Decreased parietal cell secretory capacity following vagotomy and pyloroplasty. J Surg Res 1989; (46):490-495.
143) Zucker KA, Bilchik AJ, MODLIN IM, Adrian TE. Prostaglandin E analogue inhibition of pancreatic enzyme secretion. Pancreas 1989; 4 (6):708-714.
144) Zdon MJ, Lewis JJ, Adrian TE, MODLIN IM. Hypergastrinemia after vagotomy is not associated with decreased gastric somatostatin. Surgery 1989; 106:1074-80.
145) Bilchik AJ, Nilsson O, MODLIN IM, Sussman J, Zucker KA, Adrian TE. H2-receptor blockade induces peptide YY and enteroglucagon-secreting gastric carcinoids in mastomys. Surgery 1989; 106:1119-27.
146) Zucker KA, Adrian TE, Bilchik AJ, MODLIN IM. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals. Am J Physiol 1989; 257(4 pt 1):G511-G516.
147) MODLIN IM, Bilchik AJ, Zucker KA, Adrian TE, Sussman J, Graham SM. Cholecystokinin augmentation of 'surgical' pancreatitis. Benefits of receptor blockade. Arch Surg 1989; 124(5):574-578.
148) Lewis JJ, Goldenring JR, Asher VA, MODLIN IM. Pancreastatin: A novel peptide inhibitor of parietal cell signal transduction. Biochem Biophys Res Comm 1989; 163(2):667-673.
149) McMillen MA, Schaefer HC, MacArthur JD, Adrian TA, MODLIN IM. Cyclosporine inhibits protein kinase C-dependent signals in human peripheral blood lymphocytes. J Surg Res 1989; 46:292-295.
150) Adrian TE, Zucker KA, Bilchik AJ, MODLIN IM. Time course of CCK stimulated acinar secretion and its inhibition by L364718; monitored using a novel micro-method. Internat J Pancreat 1989.
151) Ballantyne GH, Zdon MJ, Zucker KA, MODLIN IM. cAMP and calcium mediated modulation of intrinsic factor secretion in isolated rabbit gastric glands. J Surg Res 1989; 46:241-245.
152) Basson MD, Fielding L, Bilchik AJ, Zucker KA, Ballantyne GH, Sussman J, Adrian TE, MODLIN IM. Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction? Am J Surg 1989; 157(1):109-115.
153) Longo WE, Ballantyne GH, Vukasin AP, Bilchik AJ, Adrian TE, MODLIN IM. Differential release of pepride YY from colonic cells: A unique, specific, and nonneural mediated mechanism. Surg Forum 1988; 39:182-183.
154) Zucker KA, Adrian TE, MODLIN IM. Current Research Review. Cholecystokinin receptor antagonists. J Surg Res 1988; 45:496-504.
155) Zucker KA, Adrian TE, Ballantyne GH, MODLIN IM. Prostaglandin E analogue inhibition of intrinsic factor release. Scand J Gastro 1988; 650-654.
156) Lewis JJ, Zdon MJ, Adrian TE, MODLIN IM. Pancreastatin: A novel peptide inhibitor of parietal cell secretion. Surgery 1988; 104:1031-1036.
157) Oddsdottir M, Goldenring JR, Adrian TE, Zdon MJ, Zucker KA, MODLIN IM. Identification and characterization of a cytosolic 30 kDa histamine stimulated phosphoprotein in parietal cell cytosol. Biochem Biophys Res Comm 1988; 154(2): 489-496.
158) Basson MD, Sussman J, Adrian TE, MODLIN IM. Association of massive pepsin release with "stress" gastritis. Surg Forum 1988; 39:125-127.
159) Basson MD, Adrian TE, MODLIN IM. Dissociation of pepsinogen and acid secretion in the guinea pig. Gastroenterology 1988; 95(2):321-326.
160) Rackoff PJ, Zdon MJ, Tyshkov M, MODLIN IM. Epidermal growth factor (EGF) inhibits both intrinsic factor secretion and acid secretion in histamine-stimulated isolated gastric glands. Reg Pep 1988; 21: 279-287.
161) MODLIN IM, Zucker KA, Zdon MJ, Sussman J, Adrian TE. Characteristics of the spontaneous gastric endocrine tumor of Mastomys. J Surg Res 1988; 44:205-215.
162) Adrian TE, Ballantyne GH, Zucker KA, Zdon MJ, Tierney R, MODLIN IM. Lack of peptide YY immunoreactivity in adenomatous colonic polyps: evidence in favor of an adenoma-carcinoma sequence. J Surg Res 1988; 44:561-565.
163) Basson MD, Zucker KA, Adrian TE, Zdon MJ, Ballantyne GH, MODLIN IM. Pepsin release by prostaglandin E1 analogue: A potential therapeutic problem. Arch Surg 1988; 123(4): 431-433.
164) Ballantyne GH, Esterline WJ, Zdon MJ, Zucker KA, Adrian TE, MODLIN IM. Histamine stimulated acid secretion in the isolated perfused porcine stomach: An in vitro model of acid secretion. Surg Res Comm 1988; 3:199-206.
165) Basson MD, MODLIN IM. Current Research Review: Pepsinogen: Biological and pathophysiologic significance. J Surg Res 1988; 44: 82-97.
166) Goldenring JR, Oddsdottir M, MODLIN IM. A novel protein kinase activity in rabbit gastric gland cytosol. Biochem Biophys Res Commun 1987; 142: 559-566.
167) MODLIN IM, Schafer DE, Ballantyne GH, Fratesi GR, Tyshkov M, Zdon MJ. Isolated gastric glands in the study of gastric secretory relationships. Surg Res Comm 1987; 1(2):81-96.
168) Zucker KA, Zdon MJ, Adrian TE, Ballantyne GH, MODLIN IM. Prostaglandin inhibition of acid is cAMP dependent. J Surg Res 1987; 42:513-520.
169) Zucker KA, Adrian TE, Sussman JE, MODLIN IM. New potent cholecystokinin antagonists block cerulein-induced pancreatitis. Surg Forum 1987; 38:142-144.
170) Zucker KA, Adrian TE, Zdon MJ, Ballantyne GH, MODLIN IM. Asperlicin: A unique non-peptide cholecystokinin antagonist. Surgery 1987; 102(2):163-170.
171) Zdon MJ, MODLIN IM, Ballantyne GH, Zucker KA, Rackoff P. Proton pump inhibition as evidence for separate intracellular mechanisms of acid and intrinsic factor secretions. Surg Res Commun 1987; 1(4):293-302.
172) Zdon MJ, Zucker KA, Adrian TE, MODLIN IM. Somatostatin analogue inhibition of isolated parietal cell secretion. Surgery 1987; 102:967-973.
173) Oddsdottir M, MODLIN IM, Zucker KA, Zdon MJ, Goldenring JR. A Calmodulin-dependent kinase in parietal cells. Biochem Biophys Res Commun 1987; 148:1390-1397.
174) MODLIN IM, Oddsdottir M, Adrian TE, Zdon MJ, Zucker KA, Goldenring JR. A specific histamine-stimulated phosphoprotein in isolated parietal cells. J Surg Res 1987; 42:348-353.
175) Cambria RP, Neville R, Ballantyne GH, Zdon MJ, Zucker KA, Adrian TE, MODLIN IM. Somatostatin and analogs lack splanchnic vasoconstrictive effects in anesthetized pigs. J Surg Res 1987; 43:452-459.
176) Basson MD, Adrian TE, MODLIN IM. Physiologic significance of cholecystokinin in mammalian pepsinogen secretion. Surg Forum 1987; 38:116-118.
177) Oddsdottir M, Ballantyne GH, Adrian TE, Zdon MJ, Zucker KA, MODLIN IM. Somatostatin inhibition of intrinsic factor secretion from isolated guinea pig gastric glands. Scand J Gastroenterol 1987; 22:233-238.
178) Ballantyne GH, Zdon MJ, Schafer DE, Fratesi GR, Roberts JR, Tyshkov M, MODLIN IM. Evidence for dual modulation of pepsinogen secretion using Isoproterenol, Carbachol, CCK-8, Forskolin, 8 Bromo-cAMP, and A23187 probes. Ann Surg 1986, 204(5):559-565.
179) Goldenring JR, MODLIN IM, Tyshkov M, Zdon MJ, Schafer DE, Ballantyne GH. A manganese-dependent protein kinase in gastric gland cytosol. Surgery 1986; 100(2):181-187.
180) Oddsdottir M, Goldenring JR, Tyshkov M, Zucker KA, Zdon MJ, MODLIN IM. Characterization of a parietal cell cytosolic calmodulin-dependent kinase system. Surg Forum 1986; 37:177-179.
181) Ballantyne GH, Zdon MJ, Zucker KA, Tyshkov M, Fratesi GR, Schafer DE, MODLIN IM. Vasoactive intestinal peptide (VIP) augments cholecystokinin-8- (CCK-8) stimulated pepsinogen secretion: Evidence for dual modulation of chief cell function. J Surg Res 1986; 40(6):617-623.
182) MODLIN IM, Fratesi GR, Schafer DE, Zdon MJ, Ballantyne GH, Tyshkov M. Paradoxical effect of trifluoperazine, a calmodulin antagonist, on pepsinogen secretion. J Surg Res 1986; 40(6):624-631.
183) Zdon MJ, Ballantyne GH, Schafer DE, Tyshkov M, Cambria RP, MODLIN IM. Proton Pump Inhibition - The Ultimate Control of Acid Secretion? J Surg Res 1986; 40:353-361.
184) Zdon MJ, Ballantyne GH, Schafer DE, Tyshkov M, Cambria RP, MODLIN IM. Evidence for non-gastrin mediated somatostatin inhibition of parietal cell function. Surgery 1986; 100(6):954-961.
185) MODLIN IM, Schafer DE, Tyshkov M, Ballantyne GH, Fratesi GR, Roberts JR, Zdon MJ. Forskolin-dependent (cyclic adenosine monophosphate) protein phosphorylation in isolated gastric glands. Arch Surg 1986; 121(3):330-337.
186) Fratesi GR, Zdon MJ, Ballantyne GH, Schafer DE, Roberts JR, Tyshkov M, MODLIN IM. Isolated gastric glands: An in-vitro model of gastric secretion. Curr Surg 1986; 43(3):205-207.
187) Ballantyne GH, Zdon MJ, Schafer DE, Fratesi GR, Roberts JR, Tyshkov M, MODLIN IM. Evidence for dual modulation of pepsinogen secretion using isoproterenol, carbachol, CCK-8, Forskolin, 8 Bromo-cAMP and A23187 probes. Ann Surg 1986; 204(5):559-565.
188) Ballantyne GH, MODLIN IM, Zdon MJ, Tyshkov M, Fratesi GR, Schafer DE. Intracellular modulation of parietal cell macromolecular secretion. Surg Forum 1985; 36:128-130.
189) Zdon MJ, Ballantyne GH, Schafer DE, Fratesi GR, Roberts JR, Tyshkov M, MODLIN IM. The effects of cholecystokinin on parietal cell secretion in isolated gastric glands. Surgery 1985; 98(6):1038-1044.
190) MODLIN IM, Albert DL, Crochelt R, Sank A, Materia A, Jaffe BM. Bombesin and insulin stimulated pancreatic polypeptide release as a discriminator of vagal integrity. Surg Gynecol Obstet 1983 Jun; 156(6):729-736.
191) Valenzuela JE, Lamers CB, MODLIN IM, Walsh JH. Cholinergic component in the human pancreatic secretory response to intraintestinal oleate. Gut 1983; 24(9): 807-811.
192) Weber C, MODLIN IM, DiBella F, LoGerfo P, Hardy M, Feind C, Reemtsma K. Pancreatic polypeptide (PP) immunoreactivity in human parathyroid culture media. J Surg Res 1983; 35(5): 21-425.
193) MODLIN IM, Jaffe BM, Albert D, Sank A, Materia A, Crochelt R. Cholinergic stimulation of pancreatic polypeptide release by a meal, bombesin, neurotensin, tetragastrin, cholecystokinin and cerulein. J Surg Res 1983; 35(2):113-118.
194) Mitchell JJ, MODLIN IM, D`Sa AA, Barros SR, Bloom SR. Pharmacokinetics of VIP in dog and pig. Experientia 1982; 38(9):1091-1093.
195) Materia A, Jaffe BM, MODLIN IM, Sank A, Albert D. Effect of methionine-enkephalin and naloxone on bombesin-stimulated gastric acid secretion, gastrin, and pancreatic polypeptide release in the dog. Ann Surg 1982; 196(1):48-52.
196) Materia A, MODLIN IM, Sank AC, Albert D, Jaffe BM. Opiate modulation of pancreatic polypeptide release by a meal in the dog. J Pharmacol Exp Ther 1982; 223(2):355-358.
197) Zinner MJ, Kasher F, MODLIN IM, Jaffe BM. Effect of xenopsin on regional blood flow, hormone release and gastric acid secretion. Am J Physiol 1982; 243(3): G195-G199.
198) Jaffe BM, Akande B, MODLIN IM, Albert D, Reilly P. Cholinergic modulation of substance P release. Dig Dis Sci 1982 Jan; 27(1): 28-32.
199) Sank AC, MODLIN IM, Jaffe BM, Albert DL, Crochelt R. Unreliability of bombesin as a diagnostic test for retained antrum. Surg Forum 1981; 32: 214-216.
200) MODLIN IM, Albert DL, Crochelt R, Sank AC, Materia A, Jaffe BM. Bombesin and insulin stimulated pancreatic polypeptide release as a discriminator of vagal integrity. Surg Forum 1981; 32:211-214.
201) Albert DL, Koenig M, Crochelt R, Sank A, Materia A, MODLIN IM, Andersen DK. Enhancement of sensitivity to insulin by pancreatic resection. Surg Forum 1981; 32:205-207.
202) MODLIN IM, Albert D, Crochelt R, Sank A, Jaffe BM. Evidence for an intestinal mechanism of pancreatic polypeptide release. Dig Dis Sci 1981; 26(7):587-590.
203) MODLIN IM, Albert D, Sank A, Materia A, Crochelt R, Jaffe BM. Role of the antrum in the modulation of plasma pancreatic polypeptide levels. J Surg Res 1981; 30(3):269-275.
204) Materia A, MODLIN IM, Albert D, Sank A, Crochelt RF, Jaffe BM. Effect of somatostatin and 16,16-Dimethyl-prostaglandin E2 on bombesin-stimulated canine gastric acid, plasma gastrin and pancreatic polypeptide secretion. Regul Pep 1981; 1(4): 297-305.
205) MODLIN IM, Lamers CBH, Walsh JH. Stimulation of canine pancreatic polypeptide, gastrin and gastric acid secretion by ranatensin, litorin, bombesin nonapeptide and substance P. Regul Pept 1981; 1(4):279-288.
206) MODLIN IM, Ehrlich BE, Lamers CBH, Diamond JM, Walsh JH. Variable effect of lithium on canine pancreatic polypeptide and gastrin release by a meal or bombesin. Digestion 1981; 22(4):177-184.
207) MODLIN IM, Albert D, Sank A. Current aspects of gut hormones. J Surg Res 1981; 30(6):602-618.
208) Varner AA, MODLIN IM, Walsh JH. High potency of bombesin for stimulation of human gastrin release and gastric acid secretion. Regul Pept 1981; 1(4):289-296.
209) MODLIN IM, Lamers CHB, Walsh JH, Jaffe BM. Bombesin - a vagally independent stimulator of gastrin release. Am J Surg 1981; 141(1): 98-104.
210) Akande B, Reilly P, MODLIN IM, Jaffe BM: RIA measurement of Substance P following a meat meal. Surgery 1981; 89(3): 378-383.
211) MODLIN IM, Lane FC, Albert D, Sank A, Crochelt R, Beyer M, Jaffe BM. Failure of pancreatic polypeptide release by pancreatic transplants. Surg Forum 1980; 31:209-210.
212) Morley JE, Varner A, MODLIN IM, Carlson HE, Braunstein GD, Walsh JH, Herschman JM. Failure of bombesin to alter anterior pituitary hormone secretion in man. Clin Endocrinol 1980; 13(4):369-373.
213) MODLIN IM, Lamers CBH, Jaffe BM. Evidence for cholinergic dependence of pancreatic polypeptide (PP) release by bombesin - a possible application. Surgery 1980; 88(1):75-85.
214) MODLIN IM, Jaffe BM. The clinical usefulness of glucagon. Surgery 1980; 87(4):470-472.
215) MODLIN IM, Lamers CBH, Walsh JH. Mechanisms of gastrin release by bombesin and food. J Surg Res 1980; 28(6): 539-546.
216) Christofides ND, Sarson DL, Albuquerque RH, Adrian TE, Ghatei MA, MODLIN IM, Bloom SR. Release of gastrointestinal hormones following an oral water load. Experientia 1979; 35(11): 1521-1523.
217) MODLIN IM, Lamers C, Shulkes A, Walsh JH. Release of vasoactive intestinal polypeptide (VIP) from the pancreas. Surg Forum 1979; 30:405-407.
218) MODLIN IM, Bloom SR. VIP and the WDHA syndrome. Gastroenterology 1979; 76(5):1078-1079.
219) Christofides ND, MODLIN IM, Bloom SR. Effect of motilin on the rate of gastric emptying and gut hormone release during breakfast. Gastroenterology 1979; 76: 903-907.
220) MODLIN IM, Hansky J, Singer M, Walsh JH. Evidence that the cholinergic enteropancreatic reflex may be independent of cholecystokinin release. Surgery 1979; 86(2):352-361.
221) Christofides N, MODLIN IM, Sarsin D, Adrian T, Bloom SR. The release of gastrin, PP, VIP, and motilin after an oral water load and atropine in man. Clin Sci Mol Med 1978; 75(6):1051-1054.
222) MODLIN IM, Mitchell SJ, Bloom SR. Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome. Gastroenterology 1978; 75(6):1051-1054.
223) MODLIN IM Mitchell S, Bloom SR. Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia. Experientia 1978; 34(4): 535-536.
224) MODLIN IM,Bloom SR, Mitznegg P. Motilin release in the pig. Gut 1978; 19(5): 399-402.
225) Bryant MG, Polak JM, MODLIN IM, Bloom SR, Albuquerque RH, Pearse AG. Possible dual role for vasoactive intestinal peptide as a gastrointestinal hormone and neurotransmitter substance. Lancet 1976 May; 1(7967):991-993.

Back to Bibliography